About
Technology
Issues
FAQ
Links
Official Page
Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.